Investment Intelligence Workstation
Baseline Fabric Moderate risk persona
Active Workspace
Marchi Family
Julio Marchi Long-Term Growth

Thesis Refresh

Refresh the live thesis, posture, and review state for JNJ without leaving the surrounding evidence, plan, and report context.

Current Posture
Ready
Review Status
Needs Update
Review Date
Feb 28, 2025
Evidence Trail
0 notes linked to this asset

Thesis Decision

Keep the decision record explicit here. Use the side panels when the thesis needs evidence context, operating-plan thresholds, or a deeper report review before the next action.

Core Thesis

Operator Note

Optional. If you fill this in, a concise thesis-review entry is added to the durable review log using the review date above.

Back to Watchlist

Evidence Snapshot

0 research notes on file

No research notes are on file for this asset yet. Add evidence before treating the thesis as well-supported.

Operating Plan
Edit Plan
Upgrade JNJ only if the defensive income thesis still offsets litigation and pipeline risk; otherwise stand aside.
Below invalidation Mapped to latest ingested price $161.26
$154.00 $175.00
Invalidate $165.00 Entry Low $154.00 Entry High $160.00 Trim $175.00 Current $161.26
Entry: +0.8% above zone Trim: +8.5% to target Risk: +2.3% below invalidation
Review Apr 24, 2026 38 days overdue Cadence 30d
Entry Zone $154.00 - $160.00
Trim $175.00
Invalidate $165.00
Monitor: Review litigation reserve updates, MedTech execution, and dividend coverage before the next decision.
Execution: If the invalidation threshold stays broken, do not average down until the thesis is rewritten.

Recent Reviews

No review-log entries are recorded yet for this item. Open the full review log flow when you need a longer decision record.